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Molecular chaperonea b s t r a c t
ERp57 is a ubiquitous ER chaperone that has disulﬁde isomerase activity. Here, we found that both
ERp57 and gastric H+,K+-ATPase are expressed in a sample derived from the apical canalicular mem-
branes of parietal cells. Overexpression of ERp57 in HEK293 cells stably expressing H+,K+-ATPase sig-
niﬁcantly increased the ATPase activity without changing the expression level of H+,K+-ATPase.
Interestingly, overexpression of a catalytically inactive mutant of ERp57 (C57S/C60S/C406S/C409S)
in the cells also increased H+,K+-ATPase activity. In contrast, knockdown of endogenous ERp57 in
H+,K+-ATPase-expressing cells signiﬁcantly decreased ATPase activity without changing the expres-
sion level of H+,K+-ATPase. Overexpression and knockdown of ERp57 had no signiﬁcant effect on the
expression and function of Na+,K+-ATPase. These results suggest that ERp57 positively regulates
H+,K+-ATPase activity apart from its chaperoning function.
Structured summary of protein interactions:
ERp57 physically interacts with alphaHK by anti bait coimmunoprecipitation (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction kidney, while it is expressed in heart, skeletal muscle and brainThe lumen of endoplasmic reticulum (ER) provides a specialized
protein-folding environment. It contains molecular chaperones
such as calreticulin, calnexin and ERp57 (also named as GRP58,
ERp60, ERp61, PDI-Q2, Pdia3 or 1,25D3-MARRS) [1,2]. ERp57 is a
ubiquitous ER thiol-dependent protein disulﬁde isomerase that
promotes the formation of disulﬁde bonds during glycoprotein
folding [3–5]. Recently, it has been reported that ERp57 locates
in cellular compartments other than ER, such as cell surface, cyto-
sol and nucleus, and is involved in a variety of cellular functions
[6,7]: for instance, ERp57 at cell surface is involved in signal trans-
ductions and protein trafﬁcking. ERp57 in cytosol acts as a redox-
sensing protein by interacting with mTOR. In nucleus, ERp57 binds
to DNA and may be involved in the regulation of STAT3 signaling.
ERp57 mRNA has been detected in all the tissues of humans.
However, the expression level among tissues is variable; that is,
ERp57 is highly expressed in liver, lung, placenta, pancreas andat lower levels [8]. In gastric mucosa, several types of cells, such
as surface epithelial cells, parietal cells, mucus neck cells, chief
cells and enterochromafﬁn-like cells are present. It has been re-
ported the abundant expression of ERp57 in chief cells, mucous
neck cells and enterochromafﬁn-like cells of rat gastric mucosa
[9]. In human gastric adenocarcinoma, down-regulation of ERp57
was observed and its expression level was associated with the
postoperative survival [10].
Parietal cells secrete gastric acid (HCl) and chief cells secrete
pepsinogen which is activated by gastric acid. The morphology of
parietal cells is extremely different between resting and stimulated
phases. In resting parietal cells, tubulovesicles are present in
intracellular compartments underlying the apical canalicular
membrane and form a reticulated meshwork. Upon stimulation,
tubulovesicles fuse each other, and connect with the apical canalic-
ular membrane, resulting in massive acid secretion [11,12]. Gastric
H+ secretion is mediated by proton pump (H+,K+-ATPase), which
belongs to the family of P-type ATPases including Na+,K+-ATPase
and Ca2+-ATPase [13]. H+,K+-ATPase is expressed in both the apical
canalicular membrane and tubulovesicles of parietal cells. In this
study, we found that ERp57 is abundantly expressed in the apical
canalicular membrane of gastric parietal cells and that it
modulates H+,K+-ATPase activity.
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2.1. Materials
Anti-ERp57 mouse monoclonal antibody was obtained from
Stressgen (San Diego, CA, USA). Expression of gastric H+,K+-ATPase
was detected by using anti-H+,K+-ATPase a-subunit (aHK) rabbit
polyclonal antibody (Ab1024) [12] or anti-H+,K+-ATPase b-
subunit (bHK) mouse monoclonal antibody (2B6; Medical &
Biological Laboratories Co., Nagoya, Japan). Anti-Na+,K+-ATPase
a1 (a1NaK)-subunit mouse monoclonal (464.6) and rabbit
polyclonal (H300) antibodies were from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). SCH28080, a speciﬁc inhibitor of gastric
H+,K+-ATPase, ouabain, an inhibitor of Na+,K+-ATPase and anti-
b-actin mouse monoclonal antibody were from Sigma–Aldrich
(St. Louis, MO, USA).
2.2. Preparation of human and hog samples
Human stomachs, livers and colons were obtained from surgical
resection of Japanese patients at Toyama University Hospital in
accordance with the recommendations of the Declaration of Hel-
sinki and with the ethics committee approval. All of the patients
gave informed consent. Membrane fractions of the tissues were
prepared as previously described [14].
Hog stomachs were obtained from Toyama meat center
(Toyama, Japan). Two kinds of gastric vesicles (heavy and light
vesicles) were prepared from hog gastric mucosa as previously
described [12]. The heavy vesicles (named as SAV; stimulation-
associated vesicles) contained apical canalicular membrane of
parietal cells. The light vesicles (named as TV; tubulovesicles) con-
tained the intracellular microsomal membranes of parietal cells.
2.3. 2-D PAGE and protein sequencing
Samples were treated with ReadyPrep Rehydration/sample buf-
fer containing 8 M urea, 4% CHAPS, 50 mM dithiothreitol, 0.2% (w/
v) Bio-Lyte 3:10 ampholytes, and bromophenol blue (Bio-Rad).
Protein samples were applied onto 7-cm Ready Strip IPG strips
(pH 3–10, Bio-Rad), and the strips were rehydrated passively for
16 h. Proteins were separated in the strips by isoelectric focusing
(IEF) using the Protean IEF Cell (Bio-Rad). After equilibration with
equilibration buffers I and II (Bio-Rad), proteins were separated
along the second dimension by SDS–PAGE using 9% polyacrylamide
gel. After electrophoresis, the gels were stained with the CBB stain-
ing solution and decolorized with a solution containing 25% meth-
anol and 7% acetic acid. Amino acid sequences of the proteins
puriﬁed from the gel spots were analyzed by a protein sequencer
(PPSQ-21, Shimadzu Co.).
2.4. Western blotting
Western blotting was carried out as described previously [12].
The signals were visualized with the ECL Plus system (GE
Healthcare, Buckinghamshire, UK) and Pierce Western blotting
substrate (Thermo Fisher Scientiﬁc Inc., Rockford, USA). Antibodies
for ERp57 (1:1000), aHK (1:10000), bHK (1:5000), pepsinogen
(1:2000), b-actin (1:5000) and a1NaK (464.6; 1:5000, H300;
1:2000) were used. Horse-radish peroxidase (HRP)-conjugated
anti-IgG antibodies were used as a secondary antibody (1:5000).
2.5. Immunoprecipitation
Membrane fractions of SAV (200 lg of protein) were solubilized
in the lysis buffer (phosphate-buffered saline containing 0.5%
Triton X-100, 0.1% bovine serum albumin and 1 mM EDTA) for30 min on ice and centrifuged at 90000g for 30 min at 4 C. The
lysate was pre-cleared with protein A/G-agarose beads and the
supernatant was incubated in the presence and absence of
anti-ERp57 antibody (1:50 dilution) for 14 h at 4 C with end-
over-end rotation. Antibody-antigen complexes were incubated
with protein A/G-agarose beads for 6 h at 4 C with end-over-end
rotation. Then the beads were washed three times with the lysis
buffer and suspended in SDS sample buffer (62.5 mM Tris–HCl
(pH 6.7), 10% glycerol, 2% SDS and 2% mercaptoethanol). The sam-
ples were used for Western blotting. In the blotting, anti-ERp57
antibody was labeled with HRP using Peroxidase Labeling
Kit-NH2 (Dojindo Laboratories, Kumamoto, Japan).
2.6. Immunohistochemistry
Small pieces of isolated human gastric mucosa were embedded
in the O.C.T. compound (Sakura Finetechnical Co., Tokyo, Japan)
and were cut at 8 lm. The frozen sections were ﬁxed in ice-cold
methanol for 5 min, and treated with a solution containing
20 mM phosphate buffer (pH 7.4), 450 mM NaCl, 16.7% goat serum
and 0.3% Triton X-100 for 1 h at room temperature to block non-
speciﬁc binding of antibodies. Then, they were incubated with an
antibody for ERp57 (1:100), aHK (1:100) or pepsinogen (1:5000)
for 14 h at 4 C. Alexa Fluor 488-conjugated and 546-conjugated
anti-IgG antibodies (Invitrogen, Carlsbad, CA, 1:100) were used as
secondary antibodies. Immunoﬂuorescence images were visual-
ized using a Zeiss LSM 510 laser scanning confocal microscope.
Where noted, the periodate-lysine-paraformaldehyde (PLP)-ﬁxed
mucosa was used. In PLP ﬁxation, mucosa was incubated with
PLP containing 10 mM sodium periodate, 75 mM lysine and 2%
paraformaldehyde for 12 h at 4 C. The PLP-treated mucosa was
incubated with a series of PBS containing 5% (for 4 h), 10% (for
4 h), 15% (for 4 h) and 20% sucrose (for 12 h) at 4 C.
2.7. Plasmid construction
A full-length cDNA encoding human ERp57 was inserted into
the pcDNA3.1/Zeo (+) vector (Invitrogen) by using EcoRI and XbaI
restriction sites. For preparing the inactive mutant (ERp57-
4C/S-mutant; C57S/C60S/C406S/C409S), the QuikChange II site-di-
rected mutagenesis kit (Stratagene) and four primers (for C57S and
C60S; sence, ttcgccccctggagtggacacagcaagagacttg, and anti-sence,
caagtctcttgctgtgtccactccagggggcgaa; for C406S and C409S; sence,
ttttatgccccttggagtggtcacagtaagaacctggagc, and anti-sence, gctccag
gttcttactgtgaccactccaaggggcataaaa) were used. The mutated cDNA
sequences were veriﬁed using an ABI PRISM 310 sequencer
(Applied Biosystems).
2.8. Cell culture and exogenous expression of ERp57
HEK293 cells stably expressing a- and b-subunits of gastric
H+,K+-ATPase (HEK293-ab cells) [12,15] were maintained in
DMEM (Dulbecco’s Modiﬁed Eagle’s Medium) supplemented
with 100 units/ml penicillin, 100 lg/ml streptomycin, 0.5 mg/ml
G418, 0.2 mg/ml zeocin and 10% FBS. For transient expression
of ERp57 or ERp57-4C/S-mutant, the cells were transfected with
the vectors using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instruction. The transfected cells were
cultured for 12 h.
2.9. Transfection of siRNA
The HEK293-ab cells were transfected with 20 nM of Stealth
RNAi siRNA for ERp57 (PDIA3-HSS179018) and Stealth RNAi nega-
tive control Low GC duplex (Invitrogen) by using Lipofectamine
2000. Cells were then cultured for 48 h.
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ATP hydrolyzing activities of membranes fraction of the
HEK293-ab cells (30 lg of protein) were measured as described
previously [12,16]. To assess speciﬁc activities of H+,K+-ATPase
and Na+,K+-ATPase, 50 lM SCH28080 and 100 lM ouabain were
used, respectively.
2.11. Rubidium transport assay
The HEK293-ab cells on 6-well collagen-coated plates were
incubated in 1 ml of solution composed of 144 mM NaCl, 0.5 mM
MgCl2, 0.5 mM CaCl2, 1 mM RbCl (2  106 cpm 86Rb+), 500 lM oua-
bain, 10 lM furosemide and 5 mM HEPES-NaOH (pH 7.4) for
10 min at 37 C. Speciﬁc 86Rb+ transport activity was calculated
as difference between the activity in the presence and absence of
50 lM SCH28080. After a 10-min incubation, the cells were
washed and solubilized with 1 ml of the buffer composed of 1%
Nonidet P-40, 144 mM NaCl, 0.5 mM EDTA and 50 mM Tris–HCl
(pH 7.4). Then, radioactivity of the sample was measured.
2.12. Cell surface biotinylation
Cell surface biotinylation was performed as described previ-
ously [17]. The HEK293-ab cells on 6-well collagen-coated plates
were treated with 0.5 mg/ml sulfo-NHS-ss-biotin for 30 min at
37 C. Then, the cells were lysed with 250 ll of the solution con-
taining 1% Triton X-100, 150 mM NaCl, 0.5 mM EDTA and 50 mM
Tris–HCl (pH 7.4). The lysate was centrifuged at 15000g for
20 min at 4 C. The supernatant (500 lg of protein) was rocked
with 100 ll of avidin-agarose beads for 4 h at 4 C.
2.13. Glycosidase treatment
Membrane fractions (25 lg of protein) and the avidin-agarose
beads trapping biotinylated membrane proteins were treated with
5 units of PNGase F in a solution containing 0.1% SDS, 1% NP-40,
1 M 2-mercaptoethanol, 30 mM EDTA, and 50 mM sodium phos-
phate (pH 7.2) for 1 h at 37 C.
2.14. Statistics
Results are shown as means ± SE. Differences between groups
were analyzed by one-way analysis of variance, and correction
for multiple comparisons was made by using Tukey’s multiple
comparison test. Comparison between two groups was made by
using Student’s t test. Statistically signiﬁcant differences were as-
sumed at P < 0.05.3. Results
3.1. ERp57 is abundantly expressed in the apical canalicular
membrane of gastric parietal cells
Comparative proteome analysis with 2-D PAGE was performed
in two types of vesicles prepared from hog gastric mucosa; intra-
cellular tubulovesicles (TV) and stimulation-associated vesicles
(SAV) containing the apical canalicular membrane of parietal cells
[12]. In Fig. 1A and B, we focused on a spot of 57 kDa that was de-
tected in SAV but not in TV. The 57-kDa spot was determined to be
ERp57 by protein sequencing. Along with the proteomic analysis,
we conﬁrmed that the expression level of ERp57 in SAV was much
higher than that in TV (Fig. 1C). The expression pattern of ERp57
was similar to those of marker proteins in SAV such as K+-Cl
cotransporter 4 (KCC4) and b-actin [12]. H+,K+-ATPase a-subunit(aHK) was highly expressed in both TV and SAV (Fig. 1C). The
expression level of ERp57 in human stomach was comparable to
those of liver and colon (Fig. 1D).
3.2. Association of ERp57 with H+,K+-ATPase in SAV
To study whether ERp57 is associated with aHK in SAV, immu-
noprecipitation was performed with an anti-ERp57 antibody. The
subsequent Western blotting of the immune pellets with an anti-
aHK antibody gave a clear band for aHK (95 kDa), whereas blotting
with an anti-b-actin antibody (as a negative control) gave no band
for b-actin (42 kDa) (Fig. 1E). These results suggest that ERp57 and
H+,K+-ATPase are associated in the apical canalicular membrane of
gastric parietal cells.
3.3. Colocalization of ERp57 and aHK in gastric parietal cells
Double-labeling immunohistochemistry using antibodies for
ERp57 and aHK was performed in frozen sections of human gastric
mucosa ﬁxed with methanol (Fig. 2). Strong expression of ERp57
was observed in gastric parietal cells expressing aHK (Fig. 2A,
a–c). High magniﬁcation images showed that ERp57 was partially
colocalized (yellow color) with aHK in gastric parietal cells
(Fig. 2A, d–f). Taking into account the results in Fig. 1, areas
showing the yellow color in parietal cells (Fig. 2A, f) are suggested
to be the apical canalicular membrane. On the other hands, areas
exhibited green and red colors (Fig. 2A, f) may correspond to intra-
cellular tubulovesicles and ER, respectively.
We examined whether the immunoreactivity of anti-ERp57
antibody was affected by ﬁxation procedures. In Western blot
analysis using anti-ERp57 antibody, a single band of 57 kDa
was detected in the membrane fractions prepared from human
gastric mucosa ﬁxed with methanol, whereas the band could not
be detected in the sample ﬁxed with PLP (Supplementary
Fig. 1A). In double-labeling immunohistochemistry using anti-
ERp57 and anti-aHK antibodies, colocalization of ERp57 and aHK
was observed in frozen sections of human gastric mucosa ﬁxed
with methanol, whereas ERp57 was not colocalized with aHK in
the mucosa ﬁxed with PLP (Supplementary Fig. 1B). These results
suggest that epitope for the anti-ERp57 antibody was preserved
in the methanol-ﬁxed samples but not in the PLP-ﬁxed samples.
3.4. Lower expression level of ERp57 in chief cells
Western blotting with antibody for pepsinogen, a marker for
chief cells, gave a single band (38 kDa) in the membrane fraction
of human gastric mucosa (Fig. 2B, a). Double-labeling immunohis-
tochemistry using antibodies for ERp57 and pepsinogen was per-
formed in frozen sections of human gastric mucosa ﬁxed with
methanol. ERp57 was found to be weakly expressed in gastric chief
cells in which pepsinogen are present (Fig. 2B, b–d). High magniﬁ-
cation images also showed that localization of ERp57 was little
overlapped with that of pepsinogen in chief cells (Fig. 2B, e–g).
3.5. Stimulation of H+,K+-ATPase activity by exogenous expression of
ERp57 in the HEK293-ab cells
Because ERp57 is localized in gastric parietal cells, we examined
whether ERp57 functionally associates with H+,K+-ATPase. ERp57
and its mutant which has no disulﬁde isomerase activity (ERp57-
4C/S) [18,19] were overexpressed in the HEK293 cells stably
expressing a- and b-subunits of H+,K+-ATPase (HEK293-ab cells)
(Fig. 3). Expression levels of aHK and bHK in the ERp57- and
ERp57-4C/S-transfected cells were not signiﬁcantly different from
those in the mock-transfected cells (Fig. 3A). Cell surface biotinyl-
ation assay showed that expression level of bHK in the plasma
Fig. 1. Expression of ERp57 in SAV. (A and B) 2D-PAGE analysis of TV (A) and SAV (B). In B, an arrow indicates a spot of ERp57. (C) Western blotting was performed in TV and
SAV (30 lg of protein) with antibodies for ERp57, aHK, KCC4 and b-actin. (D) Western blotting using antibodies for ERp57 and b-actin was performed in the membrane
fractions of human liver, stomach, and colon (60 lg of protein). (E) Immunoprecipitation (IP) was performed with the detergent extracts of SAV (200 lg of protein) using anti-
ERp57 antibody and protein A/G-agarose. The detergent extract (input) and the immunoprecipitation samples (IP) with (ERp57, +) and without (ERp57, ) the antibody were
detected by Western blotting (WB) using anti-ERp57, anti-aHK and anti-b-actin antibodies.
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signiﬁcantly different from that in the mock-transfected cells (Sup-
plementary Fig. 2). These results suggest that disulﬁde isomerase
activity of ERp57 does not signiﬁcantly contribute to regulation
of H+,K+-ATPase expression in the HEK293-ab cells.
Next, we measured the SCH28080-sensitive K+ ATPase activity
(ATP hydrolyzing activity of H+,K+-ATPase) in these cells (Fig. 3B).
Interestingly, the H+,K+-ATPase activity in the ERp57- and ERp57-
4C/S-transfected cells was signiﬁcantly greater than that in the
mock-transfected cells (Fig. 3B). The SCH28080-sensitive 86Rb+
transport activity (K+ transporting activity of H+,K+-ATPase) in the
ERp57- and ERp57-4C/S-transfected cells was also signiﬁcantly
greater than that in the mock-transfected cells (Fig. 3C). These re-
sults suggest that ERp57 can regulate H+,K+-ATPase activity apart
from its chaperoning function.
We also examined expression and function of Na+,K+-ATPase in
these cells. Expression level of endogenous Na+,K+-ATPase a1-sub-
unit (a1NaK) in the ERp57- and ERp57-4C/S-tranfected cells was
not signiﬁcantly different from that in the mock-transfected cells
(Fig. 3D). In contrast to the case with H+,K+-ATPase, theouabain-sensitive K+ ATPase activity (Na+,K+-ATPase activity) was
not affected by exogenous expression of ERp57 and ERp57-4C/S
(Fig. 3E).
3.6. Inhibition of H+,K+-ATPase activity by knockdown of endogenous
ERp57 in the HEK293-ab cells
Effects of ERp57 knockdown by RNA interference (RNAi) on the
expression level of H+,K+-ATPase were checked in the HEK293-ab
cells. Expression level of endogenous ERp57 protein was drastically
reduced in the cells transfected with siRNA for ERp57 (si-ERp57
cells) compared with that in the cells transfected with the negative
control siRNA (si-NC cells) and control HEK293-ab cells that were
not transfected with any siRNAs (control cells) (Fig. 4A). Expression
level of aHK and bHK in the si-ERp57 cells was similar to that in the
si-NC and control cells (Fig. 4A and B, Supplementary Fig. 3). In
Fig. 4C, we examined the effects of knockdown of ERp57 on the
function of H+,K+-ATPase. Signiﬁcant decrease in the SCH28080-
sensitive K+-ATPase activity (H+,K+-ATPase activity) was observed
in the si-ERp57 cells but not in the si-NC cells (Fig. 4C).
Fig. 2. (A) Expression of ERp57 in parietal cells in human gastric mucosa. (a–f) Double immunostaining using antibodies for ERp57 (red) and aHK (green) was performed in
isolated human gastric mucosa. Representative pictures are shown. Original magniﬁcation 5 (a–c) and 63 (d–f). In f, cross-sections were taken along the dashed lines (I, X–
Z section; II, Y–Z section). Scale bars, 100 lm (a–c) and 10 lm (d–f). (B) Lower expression of ERp57 in chief cells. (a) Western blotting using anti-pepsinogen antibody was
performed in the membrane fraction of human gastric mucosa (30 lg of protein). A single band of 38 kDa was observed. (b–g) Double immunostaining using antibodies for
ERp57 (red) and pepsinogen (green) was performed in isolated human gastric mucosa. Representative pictures are shown. Original magniﬁcation 5 (b–d) and 40 (e–g).
Scale bars, 100 lm (b–d) and 10 lm (e–g).
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expression and activity of Na+,K+-ATPase in HEK293-ab cells.
Expression level of endogenous a1NaK in the si-ERp57 cells was
not signiﬁcantly different from that in the si-NC or control cells
(Fig. 4D and E). In contrast to the case with H+,K+-ATPase, the
knockdown of ERp57 did not affect the ouabain-sensitive K+-ATP-
ase activity (Na+,K+-ATPase activity) in the si-ERp57 cells (Fig. 4F).
4. Discussion
ERp57 has been widely known to be a ubiquitous molecular
chaperon [3,4]. In the present study, we have found the following:
(i) ERp57 was predominantly expressed in the parietal cells of hu-
man gastric mucosa. (ii) Expression level of ERp57 in the vesicles
containing apical canalicular membrane (SAV) was much higherthan that in intracellular tubulovesicles (TV) of parietal cells. (iii)
ERp57 was associated with aHK in SAV. (iv) Overexpression and
knockdown of ERp57 signiﬁcantly changed H+,K+-ATPase activity
but not Na+,K+-ATPase activity without changing the expression
level of the ATPases. Na+,K+-ATPase shares about 60% sequence
identity with H+,K+-ATPase. These results suggest that ERp57 mod-
ulates the activity of H+,K+-ATPase present in apical canalicular
membrane of gastric parietal cells. To our knowledge, this is the
ﬁrst report showing expression and function of ERp57 in parietal
cells.
In rat gastric mucosa, ERp57 was found to be expressed in chief
cells at higher level while in parietal cells at lower level [9]. In
human gastric mucosa, we found that expression level of ERp57 in
parietal cells was higher than that in chief cells. Therefore, expres-
sion level of ERp57 in the parietal and chief cells may be different
Fig. 3. Stimulation of H+,K+-ATPase activity but not Na+,K+-ATPase activity by overexpression of ERp57 and its inactive mutant. (A) Exogenous expression of ERp57 and
ERp57-4C/S mutant in HEK293-ab cells. (a) Western blotting using antibodies for ERp57, aHK, bHK and b-actin was performed in the membrane fractions of HEK293-ab cells
transfected with the pcDNA3.1/Zeo (+) vector (mock) and the vector containing ERp57 cDNA (ERp57) or ERp57-4C/S cDNA (ERp57-4C/S) (20 lg of protein). bHK was treated
with (core) and without (glycosylated) PNGase F. (b and c) Expression level of H+,K+-ATPase. Expression scores of aHK/b-actin (b) and bHK (core)/ b-actin (c) in ERp57- and
ERp57-4C/S-transfected cells were compared with those in mock-transfected cells. The value of mock-transfected cells was normalized as 100% n = 6. NS, not signiﬁcantly
different (P > 0.05). (B and C) H+,K+-ATPase activity in the mock-, ERp57- and ERp57-4C/S-transfected cells. SCH28080-sensitive K+-ATPase activity (B) and 86Rb+ transport
activity (C) were measured. The activities were calibrated by measuring expression level of aHK in the sample (B) or total cell number (C). The calibrated activity for mock-
transfected cells is normalized as 100% n = 5–6. ⁄⁄Signiﬁcantly different (P < 0.01). NS, not signiﬁcantly different (P > 0.05). (D) (a) Western blotting using antibodies for a1NaK
and b-actin was performed in the membrane fractions of HEK293-ab cells transfected with the pcDNA3.1/Zeo (+) vector (mock) and the vector containing ERp57 cDNA
(ERp57) or ERp57-4C/S cDNA (ERp57-4C/S) (30 lg of protein). (b) Expression level of Na+,K+-ATPase. Expression score of a1NaK/b-actin in ERp57- and ERp57-4C/S-transfected
cells was compared with that in mock-transfected cells. The value of mock-transfected cells was normalized as 100% n = 6. NS, not signiﬁcantly different (P > 0.05). (E)
Ouabain-sensitive K+-ATPase activity (Na+,K+-ATPase activity) in the mock-, ERp57- and ERp57-4C/S-transfected cells were measured. The activity was calibrated by
measuring expression level of a1NaK in the sample. The calibrated activity for mock-transfected cells is normalized as 100% n = 6. NS, not signiﬁcantly different (P > 0.05).
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with the antigen speciﬁcity of the anti-ERp57 antibody used in the
present study.bHK contains 9 cysteine residues and is heavily glycosylated,
whereas aHK is not glycosylated. Disulﬁde bonds of the bHK are
essential to assemble with aHK and maintain the expression level
Fig. 4. Inhibition of H+,K+-ATPase activity but not Na+,K+-ATPase activity by knockdown of endogenous ERp57. (A) Western blotting using antibodies for ERp57, aHK and b-
actin was performed in the membrane fractions of HEK293-ab cells transfected with siRNA for ERp57 (si-ERp57) or negative control siRNA (si-NC) and HEK293-ab cells that
were not transfected with any siRNAs (control) (20 lg of protein). (B) Expression level of H+,K+-ATPase. Expression score of aHK/b-actin in cells transfected with si-ERp57 was
compared with that transfected with si-NC. The value of control cells was normalized as 100% n = 6. NS, not signiﬁcantly different (P > 0.05). (C) SCH28080-sensitive K+-
ATPase activity (H+,K+-ATPase activity) in the cells transfected with si-ERp57 or si-NC and in control cells were measured. The activity was calibrated by expression level of
aHK. The calibrated activity for control cells is normalized as 100% n = 6. ⁄Signiﬁcant different (P < 0.05). NS, not signiﬁcantly different (P > 0.05). (D) Western blotting using
antibodies for ERp57 and a1NaK was performed in the membrane fractions of HEK293-ab cells transfected with si-ERp57 or si-NC and the cells that were not transfected with
any siRNAs (control). (E) Expression level of Na+,K+-ATPase. Expression score of a1NaK/b-actin in cells transfected with si-ERp57 was compared with that with si-NC. The
value of control cells was normalized as 100% n = 6. NS, not signiﬁcantly different (P > 0.05). (F) Ouabain-sensitive K+-ATPase activity (Na+,K+-ATPase activity) in the cells
transfected with si-ERp57 or si-NC and in control cells was measured. The activity was calibrated by expression level of a1NaK. The calibrated activity for control cells is
normalized as 100% n = 6. NS, not signiﬁcantly different (P > 0.05).
3904 T. Fujii et al. / FEBS Letters 587 (2013) 3898–3905of aHK and H+,K+-ATPase activity in the plasma membrane [15]. In
the present study, overexpression and knockdown of ERp57 had no
effects on the expression level of aHK and bHK. Overexpression of
the catalytically inactive mutant of ERp57 could stimulate the
H+,K+-ATPase activity. Therefore, the function of ERp57 as a disul-
ﬁde isomerase may not be signiﬁcantly involved in the glycosyla-
tion of bHK.
Recently it has been focused on unexpected functions of ERp57
other than its chaperoning function at cell surface [6]. In chick duo-
denum, ERp57 acts as a rapid response receptor for vitamin D3 and
is involved in the phosphate transport [20]. In human hepatoma
Hep3B cells, ERp57 is associated with STAT3 in the lipid raft frac-
tion of cell membrane and involved in STAT3 signal transduction
[21]. ERp57 induces the immunogenicity of tumor cell death by
controlling calreticulin exposure to cell surface in which calreticu-
lin functions as an ‘‘eat me signal’’ for dendritic cells [22]. In rat
kidney cortex, ERp57 associates with Na+–Cl cotransporter at
plasma membrane and regulates the transporter function [23].
ERp57 is located at the sperm surface and contributes to sperm-
egg fusion [24]. Cell surface ERp57 in platelet is involved in the reg-
ulation of normal platelet aggregation, dense granule secretion,
ﬁbrinogen binding, calcium mobilisation and thrombus formation
under arterial conditions. [25]. In this study, we showed a novel
function of ERp57 at the apical canalicular membrane of gastric
parietal cells; ERp57 modulates the activity of mature H+,K+-ATP-
ase apart from its chaperoning function.
In a resting phase, H+,K+-ATPase in the apical canalicular mem-
brane is involved in the basal acid secretion. Upon stimulation,
H+,K+-ATPase in both tubulovesicles and apical canalicular mem-
brane is involved in massive gastric acid secretion. We found pre-
viously that KCC4 is predominantly expressed in the apical
canalicular membrane of gastric parietal cells, and that its K+–Clcotransport is coupled with H+,K+-ATPase activity in the membrane
[11,12]. Because ERp57 is also associated with H+,K+-ATPase at the
canalicular membrane of parietal cells, it would be an interesting
subject to clarify functional association between ERp57 and KCC4.
In conclusion, ERp57 is located at the apical canalicular mem-
brane of gastric parietal cells and may regulate the H+,K+-ATPase
activity in basal gastric acid secretion.
Acknowledgments
We thank Professor Noriaki Takeguchi for great encouragement.
This work was supported in part by Grants-in-Aid for Scientiﬁc Re-
search (KAKENHI) from the Ministry of Education, Culture, Sports,
Science and Technology of Japan (to H.S.), Japan Society for the Pro-
motion of Science (JSPS) (to H.S., T.F. and T.S.) and JSPS Fellowship
(to K.F.).Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.febslet.2013.10.030.
References
[1] Bedard, K., Szabo, E., Michalak, M. and Opas, M. (2005) Cellular functions of
endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int. Rev.
Cytol. 245, 91–121.
[2] Ni, M. and Lee, A.S. (2007) ER chaperones in mammalian development and
human diseases. FEBS Lett. 581, 3641–3651.
[3] Freedman, R.B., Klappa, P. and Ruddock, L.W. (2002) Protein disulﬁde
isomerases exploit synergy between catalytic and speciﬁc binding domains.
EMBO Rep. 3, 136–140.
T. Fujii et al. / FEBS Letters 587 (2013) 3898–3905 3905[4] Sitia, R. and Braakman, I. (2003) Quality control in the endoplasmic reticulum
protein factory. Nature 426, 891–894.
[5] Coe, H. and Michalak, M. (2010) ERp57, a multifunctional endoplasmic
reticulum resident oxidoreductase. Int. J. Biochem. Cell Biol. 42, 796–799.
[6] Turano, C., Gaucci, E., Grillo, C. and Chichiarelli, S. (2011) ERp57/GRP58: a
protein with multiple functions. Cell. Mol. Biol. Lett. 16, 539–563.
[7] Aureli, C., Gaucci, E., Arcangeli, V., Grillo, C., Eufemi, M. and Chichiarelli, S.
(2013) ERp57/PDIA3 binds speciﬁc DNA fragments in a melanoma cell line.
Gene 524, 390–395.
[8] Koivunen, P., Horelli-Kuitunen, N., Helaakoski, T., Karvonen, P., Jaakkola, M.,
Palotie, A. and Kivirikko, K.I. (1997) Structures of the human gene for the
protein disulﬁde isomerase-related polypeptide ERp60 and a processed gene
and assignment of these genes to 15q15 and 1q21. Genomics 42, 397–404.
[9] Iida, K.I., Miyaishi, O., Iwata, Y., Kozaki, K.I., Matsuyama, M. and Saga, S. (1996)
Distinct distribution of protein disulﬁde isomerase family proteins in rat
tissues. J. Histochem. Cytochem. 44, 751–759.
[10] Leys, C.M., Nomura, S., LaFleur, B.J., Ferrone, S., Kaminishi, M., Montgomery, E.
and Goldenring, J.R. (2007) Expression and prognostic signiﬁcance of
prothymosin-alpha and ERp57 in human gastric cancer. Surgery 141, 41–50.
[11] Fujii, T., Takeguchi, N. and Sakai, H. (2011) Function of K+–Cl cotransporters
in the acid secretory mechanism of gastric parietal cells. Biol. Pharm. Bull. 34,
810–812.
[12] Fujii, T., Takahashi, Y., Ikari, A., Morii, M., Tabuchi, Y., Tsukada, K., Takeguchi, N.
and Sakai, H. (2009) Functional association between K+–Cl cotransporter-4
and H+,K+-ATPase in the apical canalicular membrane of gastric parietal cells.
J. Biol. Chem. 284, 619–629.
[13] Bublitz, M., Poulsen, H., Morth, J.P. and Nissen, P. (2010) In and out of the
cation pumps: P-type ATPase structure revisited. Curr. Opin. Struct. Biol. 20,
431–439.
[14] Sakai, H., Suzuki, T., Takahashi, Y., Ukai, M., Tauchi, K., Fujii, T., Horikawa, N.,
Minamimura, T., Tabuchi, Y., Morii, M., Tsukada, K. and Takeguchi, N. (2006)
Upregulation of thromboxane synthase in human colorectal carcinoma and
the cancer cell proliferation by thromboxane A2. FEBS Lett. 580, 3368–3374.
[15] Kimura, T., Tabuchi, Y., Takeguchi, N. and Asano, S. (2002) Mutational study on
the roles of disulﬁde bonds in the beta-subunit of gastric H+,K+-ATPase. J. Biol.
Chem. 277, 20671–20677.[16] Fujii, T., Takahashi, Y., Itomi, Y., Fujita, K., Morii, M., Tabuchi, Y., Asano, S.,
Tsukada, K., Takeguchi, N. and Sakai, H. (2008) K+–Cl cotransporter-3a up-
regulates Na+,K+-ATPase in lipid rafts of gastric luminal parietal cells. J. Biol.
Chem. 283, 6869–6877.
[17] Morii, M., Yamauchi, M., Ichikawa, T., Fujii, T., Takahashi, Y., Asano, S.,
Takeguchi, N. and Sakai, H. (2008) Involvement of the H3O+-Lys-164-Gln-161-
Glu-345 charge transfer pathway in proton transport of gastric H+,K+-ATPase.
J. Biol. Chem. 283, 16876–16884.
[18] Hirano, N., Shibasaki, F., Sakai, R., Tanaka, T., Nishida, J., Yazaki, Y., Takenawa,
T. and Hirai, H. (1995) Molecular cloning of the human glucose-regulated
protein ERp57/GRP58, a thiol-dependent reductase. Identiﬁcation of its
secretory form and inducible expression by the oncogenic transformation.
Eur. J. Biochem. 234, 336–342.
[19] Li, Y. and Camacho, P. (2003) Ca2+-dependent redox modulation of SERCA 2b
by ERp57. J. Cell Biol. 164, 35–46.
[20] Nemere, I., Farach-Carson, M.C., Rohe, B., Sterling, T.M., Norman, A.W., Boyan,
B.D. and Safford, S.E. (2004) Ribozyme knockdown functionally links a
1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate
uptake in intestinal cells. Proc. Natl. Acad. Sci. USA 101, 7392–7397.
[21] Sehgal, P.B., Guo, G.G., Shah, M., Kumar, V. and Patel, K. (2002) Cytokine
signaling: STATS in plasma membrane rafts. J. Biol. Chem. 277, 12067–12074.
[22] Obeid, M. (2008) ERP57 membrane translocation dictates the immunogenicity
of tumor cell death by controlling the membrane translocation of calreticulin.
J. Immunol. 181, 2533–2543.
[23] Wyse, B., Ali, N. and Ellison, D.H. (2002) Interaction with grp58 increases
activity of the thiazide-sensitive Na–Cl cotransporter. Am. J. Physiol. Renal
Physiol. 282, F424–F430.
[24] Ellerman, D.A., Myles, D.G. and Primakoff, P. (2006) A role for sperm surface
protein disulﬁde isomerase activity in gamete fusion: evidence for the
participation of ERp57. Dev. Cell 10, 831–837.
[25] Holbrook, L.M., Sasikumar, P., Stanley, R.G., Simmonds, A.D., Bicknell, A.B. and
Gibbins, J.M. (2012) The platelet-surface thiol isomerase enzyme ERp57
modulates platelet function. J. Thromb. Haemost. 10, 278–288.
